previous compound ID: 1503 next compound
InChIKey: NOJMTMIRQRDZMT-GSPXQYRGSA-N
SMILES: CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "GW Carlile" "DY Thomas" "J Liao" "E Matthes" "D Rotin" "J Goepp" "JW Hanrahan" "R Robert" "SD Macknight"

chemical graph of compound 1503





CID is 31100
synonyms found at PubChem are:
BROMOCRIPTINE MESYLATE, Bromocriptine mesilate, Bromocryptine mesylate, Pravidel, Bagren, 22260-51-1, Bromergon, CB-154 mesylate, UNII-FFP983J3OD, 2-Bromo-alpha-ergocryptine mesylate, Bromocriptine methanesulfonate, Bromocryptine methanesulfonate, CB 154, Bromocriptine (mesylate), EINECS 244-881-1, FFP983J3OD, 2-Bromo-alpha-ergocryptine methanesulfonate, CHEBI:3182, 2-Bromine-alpha-ergocryptine methanesulfonate, 2-Bromo-alpha-ergokryptine-mesilate [German], CB-154, 2-Bromoergocryptine monomethanesulfonate (salt), Parlodel (TN), 2-Bromoergocryptine, alpha-Ergocryptine, 2-bromo-, methanesulfonate, 2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate, (+)-Bromocriptine methanesulfonate, Cycloset, oline-9-carboxamide methanesulfonate, Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-, NSC169774, 2-Bromoergocryptine Mesylate, SR-01000597796, Bromocriptine mesylate [USAN], SR-01000075356, C32H40BrN5O5.CH4O3S, Bromocriptine mesylate [USAN:USP], (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt), (6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quin, 2-Bromo-alpha-ergokryptine-mesilate, Prestwick_771, CAS-22260-51-1, AC1L1KXP, DSSTox_CID_197, DSSTox_RID_75426, DSSTox_GSID_20197, SCHEMBL40559, Bromocriptine mesylate (USP), Bromocriptine mesilate (JP17), CHEMBL1200503, DTXSID6020197, CB 154 methanesulfonate (salt), 2-Bromo |A-Ergocryptine Mesylate, MolPort-006-123-738, NOJMTMIRQRDZMT-GSPXQYRGSA-N, HMS1568I04, HMS3260D03, HMS3712I04, 25614-03-3 (Parent), 2-Bromo alpha-Ergocryptine Mesylate, Tox21_303597, Tox21_500171, HY-12705A, .alpha.-Ergocryptine, methanesulfonate, AKOS015896276, CCG-220121, CCG-221475, CS-6048, LP00171, LS-7234, NSC-169774, NCGC00257268-01, NCGC00260856-01, AN-17214, 2-Bromo-a-ergocryptine methanesulfonate salt, B6298, EU-0100171, B 2134, D00780, 2-Bromo-.alpha.-ergocryptine monomethanesulfonate, 93201-EP2272825A2, 93201-EP2305633A1, I06-2158, SR-01000075356-1, SR-01000597796-1, SR-01000597796-2, (5 inverted exclamation mark |A)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Methanesulfonate, (5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate, (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman methanesulfonate, (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate, (5xi,5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman methanesulfonate (salt), (5xi,5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate (salt)